ECM
TARO

ExodusPoint Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

ExodusPoint Capital Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9,894
Closed -$870K – 1755
2019
Q4 		$870K Buy
+9,894
New +$834K 0.02% 612

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

ExodusPoint Capital Management's TARO Position: Q1 2020 in Review

ExodusPoint Capital Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2020, closing a stake of 9,894 shares — an estimated $870K sold.

ExodusPoint Capital Management first reported a position in TARO in Q4 2019 and held it in 1 quarter. The position peaked at $870K in Q4 2019. 90 funds tracked by Wall St. Rank hold TARO as of Q1 2020.

  • ExodusPoint Capital Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2020 after selling out during the quarter.
  • ExodusPoint Capital Management sold 9,894 Taro Pharmaceutical Industries Ltd. shares in Q1 2020, an estimated $870K.
  • ExodusPoint Capital Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2019 and held it in 1 quarter.
  • ExodusPoint Capital Management's Taro Pharmaceutical Industries Ltd. position peaked at $870K in Q4 2019.
  • 90 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2020.

Based on ExodusPoint Capital Management's 13F filing for Q1 2020, filed 15 May 2020.